Dysport™ is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adult patients under 65 years of age. Basically, it is an injectable used to minimize the appearance of wrinkles and frown lines in the face. It is made using small amounts of abobotulinumtoxinA. Used in very small, controlled amounts, the toxin relaxes the muscles in the face thereby allowing the overlying skin to relax.
Dysport™ has been used for years in over 26 countries and will be available in the US in July 2009. It is the first FDA approved drug of its type to compete with BOTOX®, which also uses the botulinum toxin. Dysport smoothes facial lines and wrinkles and is believed to last approximately 4 months. Dysport™ temporarily modifies the action of facial muscles, smoothing out undesirable lines between the brows, across the forehead or crow's feet to restore a more youthful, less stressed appearance.
Botox prices have steadily risen. Although stabilized now, Botox may still have a slightly higher price point in most practices than Dysport. Dysport appears to have a faster onset and it appears to maybe having a longer life span (about four months). Your individual results may vary.
